SCHEMBL719362

SCHEMBL719362

O=S(=O)(c1ccccc1)C(F)F

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.50
HTR6 P50406 1/20 0.50
ALDH1A1 P00352 3/20 0.49
APOBEC3G Q9HC16 1/20 0.46
CA1 P00915 2/20 0.46
CA2 P00918 2/20 0.46
CA12 O43570 2/20 0.46
CA9 Q16790 2/20 0.46
CA14 Q9ULX7 2/20 0.46
HSD17B10 Q99714 1/20 0.46
TDP1 Q9NUW8 1/20 0.46
CA3 P07451 1/20 0.46
CA4 P22748 1/20 0.46
CA6 P23280 1/20 0.46
CA5A P35218 1/20 0.46
CA7 P43166 1/20 0.46
PLA2G7 Q13093 1/20 0.46
CA13 Q8N1Q1 1/20 0.46
CA5B Q9Y2D0 1/20 0.46
TSHR P16473 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Iodide SCHEMBL31414542 0.97 LMNA (0.49) LMNAHTR6ALDH1A1APOBEC3GCA1
SCHEMBL8164394 0.86 CA12 (0.54) LMNAALDH1A1CA1CA2CA12
SCHEMBL1357362 0.84 HTR6 (0.50) LMNAHTR6ALDH1A1APOBEC3GCA1
SCHEMBL9734005 0.81 SOS1 (0.58) LMNAALDH1A1CA1CA2CA9
SCHEMBL7631040 0.80 HTR6 (0.46) LMNAHTR6ALDH1A1APOBEC3GCA1
SCHEMBL776304 0.80 HTR6 (0.46) LMNAHTR6ALDH1A1APOBEC3GCA1
SCHEMBL4076634 0.78 HTR6 (0.55) LMNAHTR6ALDH1A1APOBEC3GCA1
SCHEMBL9732244 0.77 CA1 (0.46) LMNAALDH1A1CA1CA2MMP2
SCHEMBL23043678 0.75 ALDH1A1 (0.48) LMNAALDH1A1HSD17B10TDP1SMN1; SMN2
SCHEMBL25187156 0.75 NPC1 (0.40) LMNAALDH1A1CA12CA14SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 424 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119944075-A Deep eutectic electrolyte based on phenylmethylsulfone and fluorine substituted derivatives thereof, preparation method thereof and lithium battery 哈尔滨工业大学(深圳)(哈尔滨工业大学深圳科技创新研究院) 2025-05-06 CN claimed
CN-119764570-A High-rate electrolyte, lithium ion battery containing same and electric equipment 孝感楚能新能源创新科技有限公司 2025-04-04 CN claimed
CN-115820073-B Super-long salt-fog-resistant waterborne graphene modified epoxy primer heavy-duty anticorrosive paint and preparation method thereof 河北悠扬时代环保科技有限公司 2024-01-30 CN claimed
CN-116364444-A High-temperature electrolyte for super capacitor 江苏国泰超威新材料有限公司 2023-06-30 CN claimed
CN-115863762-A High-voltage lithium ion electrolyte and application thereof 赣州石磊新能源科技有限公司 2023-03-28 CN claimed
CN-115832422-A Gel polymer lithium ion electrolyte and battery containing same 赣州石磊新能源科技有限公司 2023-03-21 CN claimed
CN-115820073-A Ultralong salt-fog-resistant water-based graphene modified epoxy primer heavy-duty anticorrosive paint and preparation method thereof 河北悠扬时代环保科技有限公司 2023-03-21 CN claimed
CN-100560561-C The method of optical purity alpha-difluoromethyl amine and highly-solid selectively preparation SHANGHAI INST ORGANIC CHEM (CN) 2009-11-18 CN claimed
CN-100335486-C Preparation method of [(phenyl sulfonyl) difluoro methyl] trimethyl silane SHANGHAI INST ORGANIC CHEM (CN) 2007-09-05 CN claimed
US-7087789-B2 Methods for nucleophilic fluoromethylation UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2006-08-08 US claimed
CN-1724507-A The method of optical purity α-difluoromethyl amine and highly-solid selectively preparation SHANGHAI INST ORGANIC CHEM (CN) 2006-01-25 CN claimed
CN-1724542-A The preparation method of [(benzene sulfonyl) difluoromethyl] trimethyl silane SHANGHAI INST ORGANIC CHEM (CN) 2006-01-25 CN claimed
US-20040230079-A1 Methods for nucleophilic fluoromethylation SOUTHERN CALIFORNIA, UNIVERSITY OF 2004-11-18 US claimed
WO-2004063129-A2 METHODS FOR NUCLEOPHILIC FLUOROMETHYLATION UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2004-07-29 WO claimed
US-4837327-A Process for nucleophilic fluoroalkylation of aldehydes ETHYL CORPORATION (US) 1989-06-06 US claimed
WO-2026104998-A1 SUBSTITUTED IMIDAZOPYRIDINE COMPOUND DERIVATIVES AND THEIR PHARMACEUTICAL USE AVELOS THERAPEUTICS INC. (KR) 2026-05-21 WO disclosed
EP-4094767-B1 NUCLEOTIDE AND NUCLEOSIDE THERAPEUTIC COMPOSITIONS AND USES RELATED THERETO UNIV EMORY (US) 2026-05-20 EP disclosed
US-5175302-A Nucleophilic fluoroalkylation of aldehydes ETHYL CORPORATION (US) 1992-12-29 US disclosed
US-4999429-A Process for the preparation of α,α,β-1-trifluoro-1-olefinic derivatives ETHYL CORPORATION (US) 1991-03-12 US disclosed
US-4837327-A Process for nucleophilic fluoroalkylation of aldehydes ETHYL CORPORATION (US) 1989-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040230079-A1 Methods for nucleophilic fluoromethylation PHF2, HAO2, GSTM2 LMNA 4803/4885HTR6 1076/4885ALDH1A1 1240/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.